These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 19481913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z, Widimský J, Rosa J, Wichterle D, Strauch B, Petrák O, Zelinka T, Vlková J, Masek M, Dvoráková J, Holaj R.
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women.
    Jang Y, Chae JS, Koh SJ, Hyun YJ, Kim JY, Jeong YJ, Park S, Ahn CM, Lee JH.
    Clin Chim Acta; 2008 May; 391(1-2):85-90. PubMed ID: 18328815
    [Abstract] [Full Text] [Related]

  • 8. Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population.
    Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Hussain T, Yakout S, Vinodson B, Sabico S.
    Gene; 2012 Feb 01; 493(1):142-7. PubMed ID: 22155316
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.
    Diabetes Care; 2007 Jan 01; 30(1):113-9. PubMed ID: 17192343
    [Abstract] [Full Text] [Related]

  • 10. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.
    Int J Obes (Lond); 2007 Feb 01; 31(2):213-20. PubMed ID: 16755284
    [Abstract] [Full Text] [Related]

  • 11. Adipokines and cardiometabolic profile in primary hyperaldosteronism.
    Iacobellis G, Petramala L, Cotesta D, Pergolini M, Zinnamosca L, Cianci R, De Toma G, Sciomer S, Letizia C.
    J Clin Endocrinol Metab; 2010 May 01; 95(5):2391-8. PubMed ID: 20194710
    [Abstract] [Full Text] [Related]

  • 12. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
    Grigorescu M, Radu C, Crişan D, Grigorescu MD, Serban A, Neculoiu D, Rusu M, Acalovschi M.
    J Gastrointestin Liver Dis; 2008 Jun 01; 17(2):147-54. PubMed ID: 18568135
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M.
    J Hypertens; 2007 Jan 01; 25(1):177-86. PubMed ID: 17143190
    [Abstract] [Full Text] [Related]

  • 15. Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population.
    Lee YY, Lee NS, Cho YM, Moon MK, Jung HS, Park YJ, Park HJ, Youn BS, Lee HK, Park KS, Shin HD.
    Diabet Med; 2005 May 01; 22(5):569-75. PubMed ID: 15842511
    [Abstract] [Full Text] [Related]

  • 16. Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essential hypertension.
    Turchi F, Ronconi V, di Tizio V, Boscaro M, Giacchetti G.
    Am J Hypertens; 2011 Dec 01; 24(12):1274-9. PubMed ID: 21850059
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, Altunbas H, Gökce C, Kalkan A, Yazici C.
    Metab Syndr Relat Disord; 2009 Oct 01; 7(5):427-34. PubMed ID: 19754305
    [Abstract] [Full Text] [Related]

  • 18. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
    Turchi F, Ronconi V, di Tizio V, Ceccoli L, Boscaro M, Giacchetti G.
    Nutr Metab Cardiovasc Dis; 2014 May 01; 24(5):476-82. PubMed ID: 24630976
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.